ATNF  210416C00012500

Sold all ATNF $12.50 Calls

This member connected a brokerage account and is sharing trades and portfolio performance with the community. 

Public Portfolio

Alunos

Sold 50% of ATNF $12.50 Calls

Sold 33% of ATNF $12.50 Calls

Sold 25% of ATNF $12.50 Calls

Bought 33% more ATNF $12.50 Calls

Bought 50% more ATNF $12.50 Calls

Bought 100% more ATNF $12.50 Calls

Bought ATNF $12.50 Calls

180 life sciences corp., a clinical-stage biotechnology company, engages in the development of drug candidates in the areas of inflammatory diseases, fibrosis, and pain. its product development platforms in phase iib/iii clinical trials include fibrosis an

180 Life Sciences Corp. Common Stock

Traded ATNF

Adam Collins

Bought <1% more ATNF

Bought 14% more ATNF

Sold 52% of ATNF

Riley Wong

Bought 107% more ATNF

Sold 7% of ATNF

New position in ATNF

Sold all ATNF

Swapnil Patel

Mike Pelech

Sold 19% of ATNF

Sold 16% of ATNF

Bought 360% more ATNF

Sold 65% of ATNF